Human Metapneumovirus (HMPV) is raising concerns with its increasing infections in China and other regions. While the virus ...
Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...